Ftse Mib
33.067,99
-0,30%
DAX
19.261,75
-0,22%
S&P 500
5.998,74
-0,38%
NASDAQ
19.060,48
-0,60%
Bitcoin
96.231,17
4,63%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Moleculin Biotech Inc (MBRX) Moleculin Biotech Inc (MBRX) Notizie

Moleculin Biotech Inc

MBRX
2,7445
0,1245 (4,75%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:30:01
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/11/202414:20EDGAR2Form 8-K - Current report
18/11/202414:20EDGAR2Form 8-K - Current report
18/11/202414:15PRNUSNew Findings Show Moleculin's Annamycin Overcomes Resistance..
14/11/202414:35EDGAR2Form 8-K - Current report
14/11/202414:15EDGAR2Form 8-K - Current report
14/11/202414:15PRNUSMoleculin Accelerates Planned Unblinded Data Readout for..
12/11/202414:00PRNUSMoleculin Receives Institutional Review Board Approval for..
12/11/202413:40EDGAR2Form 8-K - Current report
12/11/202413:30EDGAR2Form 8-K - Current report
11/11/202413:05PRNUSMoleculin Reports Third Quarter 2024 Financial Results and..
08/11/202423:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202423:27EDGAR2Form 8-K - Current report
05/11/202415:00PRNUSMoleculin to Report Third Quarter 2024 Financial Results on..
04/11/202414:30PRNUSMoleculin Appoints Leading Expert in Pancreatic Cancer to..
25/10/202422:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
25/10/202422:16EDGAR2Form 8-K - Current report
17/10/202414:40EDGAR2Form 8-K - Current report
17/10/202414:40PRNUSTranscript from Moleculin's Recent Virtual Acute Myeloid..
07/10/202414:30EDGAR2Form 8-K - Current report
07/10/202414:30PRNUSMoleculin to Host Virtual Acute Myeloid Leukemia KOL Event..
04/10/202415:00PRNUSMoleculin to Present at Two Upcoming Investor Conferences
02/10/202422:30EDGAR2Form 8-K - Current report
23/9/202414:00EDGAR2Form 8-K - Current report
23/9/202414:00PRNUSMoleculin Announces Positive In Vivo Efficacy Data of..
16/9/202414:31EDGAR2Form 8-K - Current report
16/9/202414:30PRNUSMoleculin Participates in Virtual Investor "What this Means"..
16/9/202414:15EDGAR2Form 8-K - Current report
13/9/202422:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/9/202422:04EDGAR2Form DEF 14A - Other definitive proxy statements
09/9/202414:15EDGAR2Form 8-K - Current report
09/9/202414:15PRNUSMoleculin Announces First Patients Treated in Phase 2..
03/9/202423:15EDGAR2Form PRE 14A - Other preliminary proxy statements
03/9/202415:15PRNUSMoleculin to Present at the H.C. Wainwright 26th Annual..
26/8/202414:30PRNUSMoleculin to Present at LIVE! with Webull Corporate Connect:..
19/8/202422:10EDGAR2Form 8-K - Current report
19/8/202422:05PRNUSMoleculin Announces Closing of up to $16.5 Million Public..
19/8/202416:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/8/202422:54EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
16/8/202414:00PRNUSMoleculin Announces Pricing of up to $16.5 Million Public..
16/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
15/8/202417:21EDGAR2Form S-1/A - General form for registration of securities..
15/8/202403:57EDGAR2Form S-1/A - General form for registration of securities..
14/8/202414:05EDGAR2Form 8-K - Current report
14/8/202414:05PRNUSMoleculin Reports Second Quarter 2024 Financial Results and..
13/8/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202415:10EDGAR2Form 8-K - Current report
05/8/202415:05EDGAR2Form 8-K - Current report
05/8/202415:05PRNUSMoleculin to Host Webcast Presentation to Discuss Recently..
Apertura: 2,58 Min: 2,54 Max: 2,75
Chiusura: 2,62

La tua Cronologia

NASDAQ
MBRX
Moleculin Biotech
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network